作者
Jung‐Min Lee,Mark F. Brady,Austin Miller,Richard G. Moore,Helen Mackay,Leah McNally,Jayanthi Lea,Daron Street,Stéphanie Lheureux,Megan McDonald,Linda Duska,Guilherme Cantuaria,Juraj Kavecansky,Charles A. Leath,Matthew A. Powell,Mark G. Cadungog,Peter G. Rose,Yong‐Man Kim,Helen Q. Huang,Michèle Provencher,Lari Wenzel,Michael A. Bookman,Elise C. Kohn,Angeles Alvarez Secord
摘要
We assessed the efficacy of cediranib, olaparib, and cediranib/olaparib compared with standard-of-care chemotherapy (SOC) in platinum-resistant or platinum-refractory epithelial ovarian cancer (PROC).